Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AUGX | Common Stock | Options Exercise | $22.4K | +10.2K | +95.88% | $2.20 | 20.8K | May 15, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AUGX | Stock Option (Right to Buy) | Options Exercise | $0 | -10.2K | -100% | $0.00* | 0 | May 15, 2023 | Common Stock | 10.2K | $2.20 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | This transaction reflects a cash exercise of a stock option, awarded under the Augmedix, Inc. 2020 Equity Incentive Plan, without a subsequent sale of the underlying shares of common stock. |
F2 | Fully vested. |